Skip to main content

Immunology

0 drugs are in development for Diabetes Mellitus, Type 1.

Companies
0
Clinical trials
31
BioSniper AIPage evidence connected

Prepared research question

Which programs lead the Diabetes Mellitus, Type 1 pipeline—and what evidence could change the picture?

Run cited research

Traceable citations · Unknowns marked

About this indication

Diabetes Mellitus, Type 1 context

Immunology·MeSH: Diabetes Mellitus, Type 1 (D003922)

Also known as: Diabetes Mellitus, Insulin Dependent, Diabetes Mellitus, Insulin-Dependent, 1, Diabetes Mellitus, Juvenile Onset, Diabetes Mellitus, Sudden Onset, Diabetes Mellitus, Type I, Diabetes, Juvenile-Onset, Diabetes, Type 1, IDDM, Insulin Dependent Diabetes Mellitus 1

Prevalence

7269.6 / 100K

Incidence

321.8 / 100K/yr

Frequently asked questions

How many clinical trials target Diabetes Mellitus, Type 1?

There are 31 clinical trials targeting Diabetes Mellitus, Type 1 tracked by BioSniper.

What is the prevalence of Diabetes Mellitus, Type 1?

The estimated prevalence of Diabetes Mellitus, Type 1 is approximately 7269.6 per 100,000 population.